Neurologic - EMD Serono Research & Development Institute, Inc.

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05650567

A Phase IIa, Randomized, Parallel, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Enpatoran in Dermatomyositis and Polymyositis Participants Receiving Standard of Care (NEPTUNIA)

Drug

M5049 

Phase

Phase II

Condition

idiopathic inflammatory myopathies, specifically dermatomyositis,DM, polymyositis, PM

Keywords

idiopathic inflammatory myopathies | dermatomyositis | DM | polymyositis | PM